Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 53 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
APOTHEEK DIRK BROECKX from Antwerpen, company number BE0434900884, closed financial year 2025 with a result of € -29,110 after tax. For that financial year APOTHEEK DIRK BROECKX recorded a gross margin of € 421,514 and equity of € 123,357. Compared with financial year 2024, the result moved from € 38,030 to € -29,110. The company made a loss. The buffer shrank hard: equity is 68 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 123,357
▼ 68% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -29,110
▼ still € 38,030 profit in 2024
Profit after tax over the fiscal year.
€ 30,363
▼ 71% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 61,857.
People and assets in 2025
7.3
▲ 1.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 377,779
▼ 4% vs 2024
€ 51,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,175
▼ 40% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 197,464
▲ 104% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 65,412
▲ 22% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 480,400 | € 508,289 | € 514,384 | € 421,514 | ▼ 18% |
| Profit after taxes | € 47,823 | € 19,764 | € 38,030 | € -29,110 | ▼ € 67,140 |
| Equity | € 324,673 | € 344,437 | € 382,467 | € 123,357 | ▼ 68% |
| Total debts | € 300,046 | € 221,912 | € 221,955 | € 322,886 | ▲ 45% |
| Cash | € 62,234 | € 88,102 | € 104,966 | € 30,363 | ▼ 71% |
| Retained profit | € 263,173 | € 282,937 | € 320,967 | € 61,857 | ▼ 81% |
| Dividend | € 0 | € 0 | € 0 | € 230,000 | |
| Bank debt | € 133,000 | € 75,000 | € 68,591 | € 0 | ▼ 100% |
| Balance sheet total | € 624,719 | € 566,349 | € 604,422 | € 446,244 | ▼ 26% |
| Employees (FTE) | 6 | 6.2 | 6.1 | 7.3 | ▲ 1.2 |
Key figures of APOTHEEK DIRK BROECKX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTHEEK DIRK BROECKX?
What happened at APOTHEEK DIRK BROECKX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Healis Holding BV stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 29,110 (▼ € 67,140 vs 2024). Source: NBB ↗
- Dirk Broeckx stepped down as director. NBB
- Healis Holding BV became a director. NBB
- Dirk Broeckx became a director. NBB
- New establishment in Antwerpen. KBO
- Start of the company according to the CBE. KBO
In short
From € 47,823 profit in 2022 to € 29,110 loss in 2025.
Paid € 52,201 in corporate taxes since 2022.
Best year ever: 2022, with € 47,823 profit.
On average € 57,700 of value added per employee in 2025.
A new publication or filing at APOTHEEK DIRK BROECKX? We notify you, reason included.
Follow APOTHEEK DIRK BROECKXDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Healis Holding, Teniers Invest comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK DIRK BROECKXThe shares are held by Healis Holding (100%) and Teniers Invest (16.9%).
Directors
According to the 2025 annual accounts
Dirk Broeckx
Bestuurder
since 2023 · until 2025
Bestuurder · represented by An De Mulder
Also active at: APOTHEEK DESSEIN, APOTHEEK ROOSEVELT, APOTHEEK SINT JACOB, Apotheek Lozie, PIERS, APOTHEEK VAN GHYSEGHEM, Panorama Operations
since 2025 · until 2031
Shareholders
100%
16.9%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Teniersplaats 2
2000 Antwerpen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Self-hosted
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
DNS
Cloudflare DNS
Website info
Features
Security
Network
Details
- Company number
- 0434.900.884
- VAT number
- BE 0434.900.884
- Registered office
- Teniersplaats 2, 2000 Antwerpen
- Names & denominations
- APOTHEEK DIRK BROECKX
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 27 July 1988
- Peppol
- Active · Active since 5 Feb 2026
- Contact
- apotheekbroeckx.be
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers